<DOC>
	<DOCNO>NCT00205322</DOCNO>
	<brief_summary>The combination oxaliplatin , 5-FU , leucovorin , capecitabine hypothesize retain potentially improve upon activity FOLFOX regimens . Additionally , use oral rather infusional 5-fu regimen represent clear advantage term patient convenience lack associate catheter-related complication .</brief_summary>
	<brief_title>Oxaliplatin , 5-FU Leucovorin Combination With Oral Capecitabine Metastatic Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>prior treatment metastatic disease PS 02 measurable disease neuropathy &gt; equal grade 2 concomitant radiation therapy systemic cancer therapy brain mets</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>